Leaving aside the question of advice, do you see simple protection products as a threat to IFAs or a stepping stone for clients? Should IFAs sell them alongside fully featured products?
I treat life and critical illness as fairly commoditised products for perfectly healthy people aged under 35. Can I do more to help them in this area?
One of the most commonly cited reasons for poor protection sales is that most of the country is unaware of the availability of these products and what support they can provide.
The Association of British Insurers (ABI) has warned the introduction of new financial authorities could lead to dual regulation for its members.
Insurers have agreed to continue not using genetic test results for the vast majority of insurance policies until 2017.
The ABI has given its backing to the Treasury's simplified products proposal and highlighted the need for a government supported replacement to payment protection insurance (PPI).
The ABI has revealed it is opposed to a public compulsion to pay for future long-term care (LTC) needs.
The Association of British Insurers has questioned the Insurance and Occupational Pensions Authority's decision to schedule a stress test during the implementation of Solvency II.
Defaqto believes the onus is on insurers to make the new ABI critical illness (CI) statement of best practice a success.
Bright Grey and Scottish Provident are remaining defiant and calling government action in the face of the European Court of Justice (ECJ) decision to ban gender based underwriting.